Rimonabant: depression and suicide.
Pharmacovigilance has revealed hundreds of reports of neuropsychiatric disorders and several deaths by suicide.
D063387:Cannabinoid Receptor Antagonists; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced*; D064420:Drug-Related Side Effects and Adverse Reactions; D005060:Europe; D006801:Humans; D009069:Movement Disorders / Q000209:etiology; D010880:Piperidines / Q000009:adverse effects; D011618:Psychotic Disorders / Q000209:etiology*; D011720:Pyrazoles / Q000009:adverse effects*; D013405:Suicide
D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles